Herbal Sleep Aid With Rx 'Reformulation' Gives FDA A Nightmare

FDA inspects Belmora's website and product labeling in March and issues a warning letter that firm’s Elavil OTC Sleep Aid is an unapproved new drug with inadequate directions for its intended use.

StormuSkyWarningSign_1200x675

Belmora LLC opened FDA officials' eyes wide not only with claims that its dietary supplement treats insomnia, but also because the product's brand contains the name ofa discontinued Rx drug, Elavil.

FDA's Office of Human and Animal Food Operations inspected Belmora's website and product labeling in March and submitted a

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation